Search results for: 'certified 5 mm nmr tubes 7 pack of 100'
-
Methylene Chloride-d2
Ref. Packaging I.E.(%) Price Add to... D023B 10 x 0.75 mL 99.8% D $129.8 D023F 1 x 25 mL 99.8% D $285.4 D023FE 1 x 10 mL 99.8% D $110.9 Show 1 more products -
25-Hydroxyvitamin D2 (25,26,27-13C3) Solution
CC6050P
2 - 4 weeks• 100 mg/mL In Ethanol
• 99% 13C, 98% CP -
-
-
Pyrex PCAV Glass Adapter
NE-CAV-JA$48.604 - 6 weeksFor Use with Controlled Atmosphere Valve (CAV) Tubes -
-
-
-
-
-
-
-
-
-
-
-
-
-
TFE Plug with knob, O-rings, nut and ferrule
NE-CAV-P$83.604 - 6 weeksFor Use with Controlled Atmosphere Valve (CAV) Tubes -
-
25-Hydroxyvitamin D2 (6,19,19-d3) Solution
CD6054P
2 - 4 weeks• 100 mg/mL In Ethanol
• 97% D, 95% CP -
25-Hydroxyvitamin D3 (6,19,19-d3) Solution
CD6105P
2 - 4 weeks• 100 mg/mL In Ethanol
• 97% D, 98% CP -
3-Epi-25-Hydroxyvitamin D3 (6,19,19-d3) Solution
CD6109P
2 - 4 weeks• 100 mg/mL In Ethanol
• 98% D, 98% CP -
-
-
Fmoc-Tryptophan(Boc)-OH-13C11, 15N2
CCN4001P01$2,150.002 - 4 weeks• 100 mg
• 98%13C, 98%15N
• 95% CP -
-
-
Fmoc-Asparagine (Trt)-OH-13C4, 15N2
CCN301P01$1,080.002 - 4 weeks• 100 mg
• 98%13C, 98%15N
• 95% CP -
-
1Α,25-Dihydroxyvitamin D2 (6,19,19-d3) Solution
CD6050P
2 - 4 weeks• 100 mg/mL In Ethanol
• 99% D, 95% CP -
1Α,25-Dihydroxyvitamin D3 (6,19,19-d3) Solution
CD6101P
2 - 4 weeks• 100 mg/mL In Ethanol
• 97% D, 96% CP -
-
-
-
Fmoc-Aspartic Acid-(OtBu)-OH-13C4, 15N
CCN371P01$1,300.002 - 4 weeks• 100 mg
• 98%13C, 98%15N
• 95% CP -
-
L-Histidine-13C6, 15N3, α,β,β,2,5-d5
CCDN1200P01
2 - 4 weeks• 100 mg• 99% 13C, 98% D, 98% 15N
• 95% CP -
L-Phenylalanine-13C9, 15N, α,β,β,2,3,4,5,6-d8
CCDN2200P01
2 - 4 weeks• 100 mg• 99% 13C, 98% D, 98% 15N
• 95% CP -
-
-
Fmoc-Glutamic Acid-(OtBu)-OH-13C, 15N
CCN901P01$1,300.002 - 4 weeks• 100 mg
• 98%13C, 98%15N
• 95% CP -
Viton Sealing O-ring
NE-CAV-SO$3.804 - 6 weeksFor Use with Pressure Valve (PCAV) and Controlled Atmosphere (CAV) Tubes -
L-Valine-13C5,15N,2,3,4,4,4-d5-(4-methyl-d3)
CCDN5000P01
2 - 4 weeks• 100 mg• 99% 13C, 98% D, 98% 15N
• 95% CP -
-
-
-
-
Viton Retaining O-ring
NE-CAV-RO$3.804 - 6 weeksFor Use with Pressure Valve (PCAV) and Controlled Atmosphere (CAV) Tubes -
-
-
L-Arginine-13C6, 15N4 Hydrochloride
CCN250P01$710.002 - 4 weeks• 100 mg
• 99% 13C, 98% 15N
• 95% CP, 97% L -
-
-
-
Aegis Retaining O-ring
NE-CAV-RO-A$61.604 - 6 weeksFor Use with Pressure Valve (PCAV) and Controlled Atmosphere (CAV) Tubes -
-
-
-
-
-
-
-
-
-
Tool for HR-MAS spacer
HZ04875$33.503-6 weeksFor use with 4mm HR-MAS rotor only (HZ05537, HZ05538, HZ07213) -
-
-
-
-
-
Tool Kit for 50 mL HR-MAS rotor
B2950$43.903-6 weeksFor use with 50 µL HR-MAS rotor only (HZ07213)
Kit contains:
• One extration tool
• One scredriver
• One depth gauge -
96 slots storage rack for Kel-F inserts
B5771$643.103-6 weeks• Ideal for storing, freezing and tracking samples
• Sturdy anodized aluminum construction render this rack autoclavable and resistant to commonly used chemicals -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1Α,25-Dihydroxyvitamin D2 (6,19,19-d3) Solution
CD6051P
2 - 4 weeks• 5 mg/mL In Ethanol
• 99% D, 95% CP -
1Α,25-Dihydroxyvitamin D3 (6,19,19-d3) Solution
CD6102P
2 - 4 weeks• 5 mg/mL In Ethanol
• 97% D, 96% CP -
-
-
-
-
-
-
-
-
-
-
-
1,2-dimyristoyl-sn-glycero-3-phosphoglycerol-d72 (DMPG-d72)
CD5054P
4 - 8 weeks• DMPG, Perdeuterated -
Dodecylphosphocholine-d38 (DPC-d38)
CD600P025$640.004 - 8 weeks• DPC, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
Cetyltrimethylammonium bromide alpha-d2 (CTAB, alpha-d2)
CD1196P
4 - 8 weeks• CTAB α-d2
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dihexanoyl-sn-glycero-3-phosphocholine-d40 (6:0 D6PC-d40)
CD5027P
4 - 8 weeksD6PC, Perdeuterated -
1,2-dioleoyl-sn-glycero-3-phosphocholine-d76 (18:1 DOPC-d76)
CD5094P
4 - 8 weeksDOPC, Perdeuterated -
1,2-dioleoyl-sn-glycero-3-phosphoglycerol-d76 (18:1 DOPG-d76)
CD5095P
4 - 8 weeksDOPG, Perdeuterated -
1,2-dimyristoyl-sn-glycero-3-phosphocholine-d72 (14:0 DMPC-d72)
CD5015P
4 - 8 weeks• DMPC, Perdeuterated -
1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-d58 (14:0 DMPE-d58)
CD5068P
4 - 8 weeks• DMPE, Perdeuterated -
1-palmitoyl-2-oleoyl-sn-glycero-phosphoglycerol-d74 (16:0-18:1 POPG-d74)
CD5084P
4 - 8 weeksPOPG, Perdeuterated -
1-palmitoyl-2-oleoyl-sn-glycero-phosphocholine-d82 (16:0-18:1 POPC-d82)
CD5093P
4 - 8 weeksPOPC, Perdeuterated -
Lauryl N,N-dimethylamine N-oxide-d31 (LDAO-d31)
CD5000P025$2,300.004 - 8 weeks• LDAO, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical Purity > 99 % -
n-decylphosphocholine-d34 (Fos-Choline-10-d34)
CD5040P025$2,860.004 - 8 weeks• Fos-Choline-10-d34, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
n-tetradecylphosphocholine-d42 (Fos-Choline-14-d42)
CD5041P025$2,860.004 - 8 weeks• Fos-Choline-14-d42, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
n-octyl b-D-glucopyranoside-d17 (OG-d17)
CD5065P025$2,860.004 - 8 weeks• OG, Deuterated on the octyl tail
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1-decanoyl-d19-rac-glycerol-d5 (10-MAG-d24)
CD5078P025$2,100.004 - 8 weeks• 10-MAG, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
-
2-Ketobutyric Acid-4-13C, 4-d1
CCD1400P1$2,070.002 - 4 weeks• Sodium Salt Hydrate
• 99% 13C, 97% D
• Contains 5-10% CD2H
• 1 g -
-
-
1,2-dihexanoyl-d22-sn-glycero-3-phosphocholine (6:0 D6PC-d22)
CD5010P025$1,520.004 - 8 weeks• D6PC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine (14:0 DMPC-d54)
CD5012P025$1,140.004 - 8 weeks• DMPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dihexanoyl-d22-sn-glycero-3-phosphoglycerol (6:0 D6PG-d22)
CD5020P025$2,860.004 - 8 weeks• D6PG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dimyristoyl-d54-sn-glycero-3-phosphoglycerol (14:0 DMPG-d54)
CD5022P025$2,860.004 - 8 weeks• DMPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dihexanoyl-d22-sn-glycero-3-phosphoethanolamine (6:0 D6PE-d22)
CD5061P025$2,860.004 - 8 weeks• D6PE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dimyristoyl-d54-sn-glycero-3-phosphoethanolamine (14:0 DMPE-d54)
CD5063P025$2,860.004 - 8 weeks• DMPE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dipalmitoyl-d62-sn-glycero-3-phosphoethanolamine (16:0 DPPE-d62)
CD5064P025$2,860.004 - 8 weeks• DPPE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dimyristoyl-d54-sn-glycero-phosphoserine (14:0 DMPS-d54)
CD5077P
4 - 8 weeks• DMPS, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-palmitoyl-d31-2-oleoyl-sn-glycero-phosphoglycerol (16:0-d31-18:1 POPG)
CD5082P
4 - 8 weeks• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 % -
1-palmitoyl-2-oleoyl-d33-sn-glycero-phosphoglycerol (16:0-18:1-d33 POPG)
CD5083P
4 - 8 weeks• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 % -
1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphocholine (14:0-d27-14:0 DMPC)
CD5013P
4 - 8 weeks• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 % -
1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphocholine (14:0-14:0-d27 DMPC)
CD5014P
4 - 8 weeks• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dipalmitoyl-d62-sn-glycero-3-phosphoglycerol (16:0 DPPG-d62)
CD5023P025$2,860.004 - 8 weeks• DPPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %
• 100mg -
1-palmitoyl-d31-2-palmitoyl-sn-glycero-3-phosphocholine (16:0-d31-16:0 DPPC)
CD5025P
4 - 8 weeks• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 % -
1-palmitoyl-2-palmitoyl-d31-sn-glycero-3-phosphocholine (16:0-16:0-d31 DPPC)
CD5026P
4 - 8 weeks• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 % -
1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphoglycerol (14:0-d27-14:0 DMPG)
CD5042P
4 - 8 weeks• DMPG, Deuterated on 1' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 % -
1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphoglycerol (14:0-14:0-d27 DMPG)
CD5052P
4 - 8 weeks• DMPG, Deuterated on 2' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 % -
1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphethanolamine (14:0-d27-14:0 DMPE)
CD5053P
4 - 8 weeks• DMPE, Deuterated on 1' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 % -
1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphoethanolamine (14:0-14:0-d27 DMPE)
CD5067P
4 - 8 weeks• DMPE, Deuterated on 2' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dioleoyl-d66-sn-glycero-3-phosphoglycerol (18:1 DOPG-d66)
CD5096P
4 - 8 weeks• DOPG, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine (16:0 DPPC-d62)
CD5016P025$1,140.004 - 8 weeks• DPPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dioleoyl-d66-sn-glycero-3-phosphocholine (18:1 DOPC-d66)
CD5074P025$7,410.004 - 8 weeks• DOPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1,2-dioleoyl-d66-sn-glycero-3-phosphoethanolamine (18:1-d33-18:1-d33 DOPE)
CD5076P
4 - 8 weeks• DOPE, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1,2-dimyristoyl-d54-sn-glycero-3-phosphoserine-d3 (14:0 DMPS-d54,d3)
CD5079P
4 - 8 weeks• DMPS, Deuterated on both acyl chains and serine
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-palmitoyl-d31-2-oleoyl-sn-glycero-phosphocholine (16:0-d31-18:1 POPC)
CD5091P
4 - 8 weeks• POPC, Deuterated on palmitate chain only
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-palmitoyl-2-oleoyl-d33-sn-glycero-phosphocholine (16:0-18:1-d33 POPC)
CD5092P
4 - 8 weeks• POPC, Deuterated on oleate chain only
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1,2-dioleoyl-d66-sn-glycero-3-phosphoethanolamine-d4 (18:1 DOPE-d70)
CD5098P
4 - 8 weeks• DOPE, Deuterated on both acyl chains and ethanolamine
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
-
1-lauroyl-2-hydroxy-d23-sn-glycero-3-phosphoglycerol (12:0 LLPG-d23)
CD5030P025$3,800.004 - 8 weeks• LLPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphoglycerol (14:0 LMPG-d27)
CD5031P025$3,800.004 - 8 weeks• LMPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphoglycerol (16:0 LPPG-d31)
CD5032P025$3,800.004 - 8 weeks• LPPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphocholine (14:0 LMPC-d27)
CD5036P025$2,860.004 - 8 weeks• LMPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphocholine, (16:0 LPPC-d31)
CD5037P025$2,860.004 - 8 weeks• LPPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-palmitoyl-d31-2-oleyl-d33-sn-glycero-phosphoserine (16:0-d31-18:1-d33 POPS)
CD5075P
4 - 8 weeks• POPS, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1,2-dihexanoyl-d22-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (6:0 D6PC-d22,d9)
CD5017P025$3,800.004 - 8 weeks• D6PC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (14:0 DMPC-d54,d9)
CD5019P025$3,800.004 - 8 weeks• DMPC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (16:0 DPPC-d62,d9)
CD5024P025$3,800.004 - 8 weeks• DPPC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
1-palmitoyl-d31-2-oleoyl-d33-sn-glycero-phosphocholine (16:0-d31-18:1-d33 POPC)
CD5071P025$7,410.004 - 8 weeks• POPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
1-palmitoyl-d31-2-oleoyl-d33-sn-glycero-phosphoglycerol (16:0-d31-18:1-d33 POPG)
CD5072P025$8,350.004 - 8 weeks• POPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 % -
-
-
-
15N Microcrystalline Ubiquitin
CN10063P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N -
15N Microcrystalline Ubiquitin
CN10063P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N -
15N Ubiquitin in Solution
CN10064P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N -
15N Ubiquitin in Solution
CN10064P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N -
-
13C, 15N Microcrystalline Ubiquitin
CCN10063P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N -
13C, 15N Microcrystalline Ubiquitin
CCN10063P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N -
15N Microcrystalline SH3
CN10053P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15N -
15N Microcrystalline SH3
CN10053P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15N -
13C, 15N Ubiquitin in Solution
CCN10064P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N -
13C 15N Ubiquitin in Solution
CCN10064P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N -
13C, 15N, D Microcrystalline Ubiquitin
CCND10063P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Microcrystalline Ubiquitin
CCND10063P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D -
15N SH3 in Solution
CN10054P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15N -
15N SH3 in Solution
CN10054P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15N -
13C, 15N Calbindin in Solution
CCN10014P10
3 - 6 weeks• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
13C, 15N Calbindin in Solution
CCN10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
13C, 15N SH3 in Solution
CCN10054P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N -
13C, 15N SH3 in Solution
CCN10054P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N -
13C, 15N, D Ubiquitin in Solution
CCND10064P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Ubiquitin in Solution
CCND10064P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D -
15N Calbindin in Solution
CN10014P10
3 - 6 weeks• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
15N Calbindin in Solution
CN10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
15N Microcrystalline GB1
CN10033P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 15N -
15N Microcrystalline GB1
CN10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 15N -
15N GB1 in Solution
CN10034P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 15N -
15N GB1 in Solution
CN10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 15N -
15N MBP in Solution
CN10044P10
3 - 6 weeks• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 15N -
15N MBP in Solution
CN10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 15N -
13C, 15N, D Microcrystalline SH3
CCND10053P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Microcrystalline SH3
CCND10053P20
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, D -
13C, 15N Microcrystalline GB1
CCN10033P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N Microcrystalline GB1
CCN10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N GB1 in Solution
CCN10034P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N GB1 in Solution
CCN10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N MBP in Solution
CCN10044P10
3 - 6 weeks• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N -
13C, 15N MBP in Solution
CCN10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N -
13C, 15N, D Calbindin in Solution
CCND10014P10
3 - 6 weeks• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D